MyAverix Finance
SW · Healthcare
COSMO Pharmaceuticals SA (COPN)
Drug Manufacturers - General
COSMO Pharmaceuticals SA (COPN) is listed on SW in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-05-24, reported market cap is $1.34B, P/E ratio is 18.00, net margin is -3.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for COPN
COSMO Pharmaceuticals SA (COPN) — FAQ
What is COSMO Pharmaceuticals SA's market cap?
COSMO Pharmaceuticals SA (COPN) has a reported market cap of $1.34B (data as of 2026-05-24).
What is COPN's P/E ratio?
The price-to-earnings (P/E) ratio for COSMO Pharmaceuticals SA (COPN) is 18.00 (data as of 2026-05-24).
Does COSMO Pharmaceuticals SA pay a dividend?
Dividend yield is not available in the current snapshot for COSMO Pharmaceuticals SA (COPN). Check the MyAverix Finance app for the latest dividend data.
What sector is COSMO Pharmaceuticals SA in?
COSMO Pharmaceuticals SA (COPN) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is COPN listed on?
COPN is listed on SW.
What is COSMO Pharmaceuticals SA's net margin?
COSMO Pharmaceuticals SA (COPN) reports a net margin of -3.5% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.